6d
Fintel on MSNBMO Capital Initiates Coverage of Rocket Pharmaceuticals (RCKT) with Outperform RecommendationFintel reports that on March 12, 2025, BMO Capital initiated coverage of Rocket Pharmaceuticals (NasdaqGM:RCKT) with a Outperform recommendation. Analyst Price Forecast Suggests 381.87% Upside As of ...
BMO Capital Markets assumed coverage on shares of Rocket Pharmaceuticals (NASDAQ:RCKT – Free Report) in a report released on Wednesday morning, Ratings reports. The brokerage issued an outperform ...
Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) have been given an average rating of “Moderate Buy” by the twelve analysts that are currently covering the company, Marketbeat ...
Michael Bromberg, MD, PhD, talks with Physician’s Weekly about renal disease in patients with paroxysmal nocturnal ...
Figure 3 outlines an algorithm, which illustrates an approach to the infant with anemia. Table 7 shows how RBC indices and characteristics are used to assist in establishing a diagnosis.
After hours: March 14 at 7:53:01 PM EDT Loading Chart for RCKT ...
After hours: March 14 at 7:26:37 PM EDT Loading Chart for JSPR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results